Sanofi India (SANOFI) Share Price hits fresh 52-week low at Rs 2,940
- October 9, 2026
- Posted by: Kunal Singla
- Category: News
Sanofi India Share Price is in focus after the stock touched a fresh 52-week low of Rs 2,940 and was trading down 1.39% at Rs 2,940, with market capitalisation at Rs 6,966.3 crore. The move is relevant because Sanofi India Share Price has reached its yearly low while the latest Univest figures also show a modest intraday range from Rs 2,981.55 to Rs 2,940. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Sanofi India Share Price Today, the event matters because it places the stock at a fresh 52-week trough while the broader Sanofi India Stock News flow remains anchored to verified price and valuation data. Univest continues to frame the move through price action, fundamentals and sector context rather than speculation.
Sanofi India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,940 |
| Previous Close | Rs 2,981.55 |
| Today's Move | Rs -41.55 (-1.39%) |
| Open | Rs 2,980.05 |
| High | Rs 2,981.55 |
| Low | Rs 2,940 |
| Market Capitalisation | Rs 6,966.3 crore |
Sanofi India Ltd. (SANOFI) traded at Rs 2,940 versus the previous close of Rs 2,981.55, a fall of 1.39%. The stock opened at Rs 2,980.05, reached a high of Rs 2,981.55, touched a low of Rs 2,940.
Sanofi India Share Price opened at Rs 2,980.05, touched a high of Rs 2,981.55, and moved to a low of Rs 2,940, which is also the fresh 52-week low. The previous close was Rs 2,981.55, so the stock was down Rs 41.55 or 1.39% at the latest check. The day’s range was narrow, and the current price sat at the bottom of that range, which is why Sanofi India Share Price Today is drawing attention in Stock Market Today screens for Stocks in News and 52 Week Low Stocks. The fresh yearly low does not by itself explain the move; it only confirms where price stood as of 09 October 2026 at 9:22 AM IST. For Sanofi India Share Price Live tracking, the key verified point is that the stock has slipped to Rs 2,940 while market capitalisation remains Rs 6,966.3 crore. That sets up the fundamental view that follows.
Sanofi India Ltd. (SANOFI) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,966.3 crore |
| P/E Ratio | 21.21x |
| P/B Ratio | 8.31x |
| ROE | 44.5% |
| ROCE | 55.46% |
| EPS | Rs 140.6 |
| Book Value Per Share | Rs 358.67 |
| Dividend Yield | 4.13% |
Sanofi India Ltd. (SANOFI) fundamental metrics show P/E 21.21x, P/B 8.31x, ROE 44.5%, ROCE 55.46%. These ratios show where the company stands today and are not a call to buy or sell.
Sanofi India Ltd. has a market capitalisation of Rs 6,966.3 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 21.21x, P/B at 8.31x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 44.5% and ROCE of 55.46%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 140.6, book value per share of Rs 358.67, dividend yield of 4.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.34x, median ROE of 11.53%, median ROCE of 13.32%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 21.21x |
| Benchmark Median P/E | 31.34x |
| Benchmark Average P/E | 47.24x |
| Benchmark P/E Range | 3.56x to 678.22x |
| Company P/B Ratio | 8.31x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 44.5% |
| Benchmark Median ROE | 11.53% |
| Company ROCE | 55.46% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 6,966.3 crore |
| Benchmark Median Market Cap | Rs 803.77 crore |
Sanofi India Ltd. (SANOFI) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sanofi India Ltd. (SANOFI) has a P/E ratio of 21.21x, which is below the benchmark median of 31.34x, a difference of -32.32%. A P/E difference of this kind is a reference point rather than a recommendation.
Sanofi India Ltd. (SANOFI) has a ROE of 44.5%, which is above the benchmark median of 11.53%, a difference of +285.95%. Sanofi India Ltd. (SANOFI) has a ROCE of 55.46%, which is above the benchmark median of 13.32%, a difference of +316.37%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Supriya Lifescience Ltd. | SUPRIYA | 6,938.82 | 34.98 | 5.68 | 19.06 | 25.3 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,208.67 | 52.41 | 5.79 | 12.11 | 17.4 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,267.04 | 63.98 | 4.69 | 11.22 | 12.41 |
| Innova Captab Ltd. | INNOVACAP | 6,673.86 | 41.38 | 5.7 | 13.75 | 15.04 |
| IOL Chemicals And Pharmaceuticals Ltd. | IOLCP | 6,469.35 | 35.92 | 3.24 | 7.9 | 10.65 |
Sanofi India Ltd. (SANOFI) has a P/E ratio of 21.21x compared with the displayed peer median of 41.38x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 44.5% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 55.46% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Sanofi India Ltd. (SANOFI) has a market capitalisation of Rs 6,966.3 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Sanofi India Ltd.
- Sanofi India Share Price touched a fresh 52-week low of Rs 2,940 while the stock was last at Rs 2,940.
- Sanofi India Share Price Today shows a 1.39% decline versus the previous close of Rs 2,981.55.
- Sanofi India Fundamental Analysis shows P/E at 21.21, P/B at 8.31, ROE at 44.5% and ROCE at 55.46%.
- Sanofi India Share Price sits above the industry median on ROE and ROCE, while P/E is below the industry median.
- Sanofi India Share News remains notable because market capitalisation is Rs 6,966.3 crore and Jun 2026 revenue was Rs 437.7 crore.
About Sanofi India Ltd.
Sanofi India Ltd. operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. Sanofi India Share Price reflects a company that is part of a large pharmaceutical ecosystem and is tracked for its earnings profile, pricing multiples and dividend record. The latest figures show revenue of Rs 437.7 crore for Jun 2026, along with EPS of Rs 140.6, book value of Rs 358.67 and dividend yield of 4.13%. Those metrics help explain why Sanofi India Stock Analysis often centres on valuation, profitability and income characteristics. Univest data also places the company within a peer group of listed pharmaceutical names of similar market capitalisation, which makes relative comparison useful. For Sanofi India Share Price, the business context is not about a single headline number; it is about how the stock trades against its earnings base, balance-sheet value and sector benchmark.
Track Sanofi India Share Price on Univest
Use Sanofi India Ltd. (SANOFI) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Sanofi India Share Price on Univest for live price updates, key ratios, market capitalisation, 52-week levels and sector context. Univest presents Sanofi India Share Price alongside fundamental metrics, peer checks and stock-specific news so readers can follow the same verified data set in one place. For Sanofi India Share Price Today, the combination of price action, valuation and industry comparison helps keep the story factual and easy to follow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Sanofi India Share Price hit a fresh 52-week low?
Ans. Sanofi India Share Price touched Rs 2,940, which is the fresh 52-week low. The price move is confirmed in Univest data; a company-specific reason has not been established. The stock was down 1.39% from the previous close.
What is Sanofi India Share Price today?
Ans. Sanofi India Share Price was last at Rs 2,940, down Rs 41.55 or 1.39%. The stock also marked a fresh 52-week low, so Sanofi India Share Price Today is currently being tracked at its yearly trough.
What is the market capitalisation of Sanofi India?
Ans. Sanofi India Share Price is being viewed alongside a market capitalisation of Rs 6,966.3 crore. That size helps place the company against listed pharmaceutical peers and the broader Healthcare sector benchmark used by Univest.
How do Sanofi India valuation ratios look?
Ans. Sanofi India Share Price is linked to a P/E of 21.21 and a P/B of 8.31. In the same-industry benchmark, the P/E sits below the median while the P/B sits above the median, showing mixed valuation signals.
What do ROE and ROCE show for Sanofi India?
Ans. Sanofi India Share Price comes with ROE of 44.5% and ROCE of 55.46%. Both are well above the same-industry benchmark medians, which indicates strong return metrics in the latest Univest comparison set.
How does Sanofi India compare with peers?
Ans. Sanofi India Share Price is near Supriya Lifescience and Bliss GVS Pharma by market cap, while its P/E is lower than several Univest peers. Its ROE and ROCE are also higher than those peer figures on the latest Univest data.
What is the book value and EPS for Sanofi India?
Ans. Sanofi India Share Price is supported by EPS of Rs 140.6 and book value of Rs 358.67. EPS reflects earnings per share, while book value shows accounting net worth behind each share in the latest figures.
Does Sanofi India pay a dividend yield?
Ans. Sanofi India Share Price includes a dividend yield of 4.13%. That is a historical payout measure linked to the current price, so it helps add income context alongside the company’s valuation and return ratios.
What should investors monitor next in Sanofi India Share News?
Ans. Sanofi India Share News should be watched for how the stock trades after the fresh 52-week low, along with any change in price action, valuation multiples and sector comparison. Univest will keep the same verified data points in view.
